Not Signed In -
Obesity |
Overweight |
Clinical Trial: An Investigational Drug Study in Obese (considerably overweight) Patients
This study is no longer recruiting patients.
|
Purpose
The purpose of this study is to determine the safety and effectiveness of an investigational drug in patients with obesity (considerably overweight).
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Obesity | Drug: Investigational weight loss drug | Phase II Phase III |
MedlinePlus related topics: Obesity
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control
Eligibility
Ages Eligible for Study: 18 Years - 65 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Patients who are obese (considerably overweight) based on body mass index.
Exclusion Criteria:
- Patients with serious or unstable current or past medical conditions
More Information
Study ID Numbers: 2005_011
Record last reviewed: April 2005
Last Updated: April 22, 2005
Record first received: April 22, 2005
ClinicalTrials.gov Identifier: NCT00109148
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-05-03
Record last reviewed: April 2005
Last Updated: April 22, 2005
Record first received: April 22, 2005
ClinicalTrials.gov Identifier: NCT00109148
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-05-03
Source: ClinicalTrials.gov
Cache Date: May 4, 2005
email this page
print this page
bookmark this page
feedback on this page
